or
forgot password

    • cancer clinical trials in cary, NC

    • ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
    Raleigh Hematology Oncology Clinic
    Cary, North Carolina 27511
    Prostate Cancer
    Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
    Raleigh Hematology/Oncology Clinic
    Cary, North Carolina 27511
    Chronic Lymphocytic Leukemia
    A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
    Raleigh Hematology Oncology Associates
    Cary, North Carolina 27511
    Lymphoma, T-Cell, Peripheral
    PhII ICb With/Without Erbitux in MBC Pts
    Raleigh Hematology Oncology Clinic
    Cary, North Carolina 27511
    Metastatic Breast Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Waverly Hematology Oncology
    Cary, North Carolina 27518
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Waverly Hematology Oncology
    Cary, North Carolina 27518
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Waverly Hematology Oncology
    Cary, North Carolina 27518
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Waverly Hematology Oncology
    Cary, North Carolina 27518
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Gemzar, Cisp, Sunitinib Urothelial Ca
    Raleigh Hematology Oncology Associates
    Cary, North Carolina 27511
    Urothelial Cancer
    Study of Immunotherapy to Treat Advanced Prostate Cancer
    Raleigh Hematology Oncology Associates
    Cary, North Carolina 27511
    Prostate Cancer
    Ixabepilone + Carboplatin Metastatic Breast Cancer
    Raleigh Hematology Oncology Associates
    Cary, North Carolina 27511
    Metastatic Breast Cancer
    Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    US Oncology - Cancer Centers of North Carolina - Cary
    Cary, North Carolina 27518
    Chronic Lymphocytic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    US Oncology - Cancer Centers of North Carolina - Cary
    Cary, North Carolina 27518
    Multiple Myeloma
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Waverly Hematology Oncology
    Cary, North Carolina 27518
    Chronic Myeloid Leukemia
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Raleigh Hematology Oncology Associates, D.B.A., Cancer Centers of North Carolina
    Cary, North Carolina 27518
    Advanced Prostate Cancer, Prostatic Neoplasms
    MaxAn Post Market Surveillance Validation
    Cary Orthopedics
    Cary, North Carolina 27518
    DDD, Deformity, Tumor, Fracture
    Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
    Waverly Hematology Oncology
    Cary, North Carolina 27518
    Multiple Myeloma
    Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
    Raleigh Hematology Oncology Clinic
    Cary, North Carolina 27511
    Metastatic Breast Cancer
    Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T
    Raleigh Hematology Oncology Associates, D.B.A., Cancer Centers of North Carolina
    Cary, North Carolina 27518
    Prostate Cancer
    Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer
    Raleigh Hematology Associates, Wake Practice
    Cary, North Carolina 27609
    Carcinoma, Non-Small-Cell Lung
    Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma
    Raleigh Hematology Oncology Clinic
    Cary, North Carolina 27511
    Lymphoma, Non-Hodgkin, Hodgkin's Lymphoma
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    Raleigh Hematology Oncology Clinic
    Cary, North Carolina 27511
    Prostate Cancer, Hormone Refractory Prostate Cancer
    A Study of ABT-751 in Patients With Renal Cell Cancer
    US Oncology Inc Raleigh Hematology Oncology Clinic
    Cary, North Carolina 27511
    Renal Cell Cancer
    Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma
    Raleigh Hematology Oncology Clinic
    Cary, North Carolina 27511
    Carcinoma, Renal Cell
    A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
    Raleigh Hematology Oncology
    Cary, North Carolina
    Non-Small Cell Lung Cancer
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Raleigh Hematology Oncology Associates
    Cary, North Carolina 27511
    Non Small Cell Lung Carcinoma
    A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma
    Raleigh Hematology Oncology
    Cary, North Carolina
    Renal Cell Carcinoma, Metastases
    Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel
    Cancer Center of North Carolina- Cary
    Cary, North Carolina
    Hormone-Refractory Prostate Cancer
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Raleigh Hematology Oncology Clinic

    Trial Locations
    Raleigh Hematology Oncology Clinic
    Raleigh Hematology Oncology Clini
    Non-Small Cell Lung Cancer
    A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine
    Raleigh Hematology Oncology Associates
    Cary, North Carolina 27511
    Breast Cancer
    Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
    Raleigh Hematology Oncology Associates
    Cary, North Carolina 27511
    Colorectal Cancer Metastatic
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Raleigh Hematology Oncology Associates
    Cary, North Carolina 27511
    Metastatic Breast Cancer
    Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
    Raleigh Hematology Oncology Associates
    Cary, North Carolina 27511
    Small Cell Lung Cancer
    Vidaza to Restore Hormone Thx Prostate
    Raleigh Hematology Oncology Associates
    Cary, North Carolina 27511
    Prostate Cancer
    Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
    Raleigh Hematology Oncology Associates
    Cary, North Carolina 27511
    Metastatic Breast Cancer